Regulation of p53 downstream genes

被引:714
作者
El-Deiry, WS
机构
[1] Univ Penn, Sch Med, Lab Mol Oncol & Cell Cycle Regulat, Howard Hughes Med Inst,Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Lab Mol Oncol & Cell Cycle Regulat, Howard Hughes Med Inst,Dept Genet, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Lab Mol Oncol & Cell Cycle Regulat, Howard Hughes Med Inst,Canc Ctr, Philadelphia, PA 19104 USA
关键词
p53; tumor suppressor; transcription; apoptosis; growth arrest; cancer;
D O I
10.1006/scbi.1998.0097
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 tumor suppressor is the most commonly mutated gene in human cancer, p53 protein is stabilized in response to different checkpoints activated by DNA damage, hypoxia, viral infection, or oncogene activation resulting in diverse biological effects, such as cell cycle arrest, apoptosis, senescence, differentiation and antiangiogenesis. The stable p53 protein is activated by phosphorylation, dephosphorylation and acetylation yielding a potent sequence-specific DNA-binding transcription factor. The wide range of p53's biological effects can in part be explained by its activation of expression of a number of target genes including p21(WAFI), GADD45, 14-3-3 sigma, bax, Fas/APO1, KILLER/DR5, PIG3, Tsp1, IGF-BP3 and others. This review will focus on the transcriptional targets of p53, their regulation: by p53, and their relative importance in carrying out the biological effects of p53.
引用
收藏
页码:345 / 357
页数:13
相关论文
共 96 条
  • [11] Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
    Canman, CE
    Lim, DS
    Cimprich, KA
    Taya, Y
    Tamai, K
    Sakaguchi, K
    Appella, E
    Kastan, MB
    Siliciano, JD
    [J]. SCIENCE, 1998, 281 (5383) : 1677 - 1679
  • [12] Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
    Carmeliet, P
    Dor, Y
    Herbert, JM
    Fukumura, D
    Brusselmans, K
    Dewerchin, M
    Neeman, M
    Bono, F
    Abramovitch, R
    Maxwell, P
    Koch, CJ
    Ratcliffe, P
    Moons, L
    Jain, RK
    Collen, D
    Keshet, E
    [J]. NATURE, 1998, 394 (6692) : 485 - 490
  • [13] MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53
    CHIN, KV
    UEDA, K
    PASTAN, I
    GOTTESMAN, MM
    [J]. SCIENCE, 1992, 255 (5043) : 459 - 462
  • [14] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
    CHO, YJ
    GORINA, S
    JEFFREY, PD
    PAVLETICH, NP
    [J]. SCIENCE, 1994, 265 (5170) : 346 - 355
  • [15] CONTROL OF ANGIOGENESIS IN FIBROBLASTS BY P53 REGULATION OF THROMBOSPONDIN-1
    DAMERON, KM
    VOLPERT, OV
    TAINSKY, MA
    BOUCK, N
    [J]. SCIENCE, 1994, 265 (5178) : 1582 - 1584
  • [16] E1A signaling to p53 involves the p19ARF tumor suppressor
    de Stanchina, E
    McCurrach, ME
    Zindy, F
    Shieh, SY
    Ferbeyre, G
    Samuelson, AV
    Prives, C
    Roussel, MF
    Sherr, CJ
    Lowe, SW
    [J]. GENES & DEVELOPMENT, 1998, 12 (15) : 2434 - 2442
  • [17] MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL
    DENG, CX
    ZHANG, PM
    HARPER, JW
    ELLEDGE, SJ
    LEDER, P
    [J]. CELL, 1995, 82 (04) : 675 - 684
  • [18] El-Deiry WS, 1998, CANCER J - FRANCE, V11, P229
  • [19] El-Deiry WS, 1998, CURR TOP MICROBIOL, V227, P121
  • [20] DEFINITION OF A CONSENSUS BINDING-SITE FOR P53
    ELDEIRY, WS
    KERN, SE
    PIETENPOL, JA
    KINZLER, KW
    VOGELSTEIN, B
    [J]. NATURE GENETICS, 1992, 1 (01) : 45 - 49